The MEDIRAD Project will have a significant impact on the scientific bases and clinical practice of radiation protection in the medical field. Keeping all stakeholders informed and up-to-date is also a key aim of the project and a range of press and dissemination material will be created at each stage of the project to announce the latest results.
Find all our press and media related items listed here.
|ECR 2019 - Article||01/03/2019||MEDIRAD_ECR Today 2019_Wednesday_Feb27.pdf|
|Folder||05/03/2019||MEDIRAD folder March 2019 web.pdf|
|ECR 2018 - Article||28/02/2018||20180228_ECR Today 2018_MEDIRAD.pdf|
|ECR 2018 - Poster||28/02/2018||201803_ESI-0080_MEDIRAD poster.pdf|
|AIR²-Special Issue MEDIRAD-January 2018||26/01/2018||air-special-issue-medirad-january-2018.pdf|
|Press release||17/10/2017||20171017_MEDIRAD_press release_final.pdf|
|Poster (ICRP, Paris, October 2017)||10/10/2017||2017_10_10-12_ICRP Paris_MEDIRAD poster.pdf|
During the course of its +4-year period, MEDIRAD researchers will publish a range of scientific articles and every effort will be made to make these available on an open-access basis.
Below you can find a list of publications related to the MEDIRAD Project, which will be updated as the project progresses.
|Automatic Tube Current Modulation and Tube Voltage Selection in Pediatric Computed Tomography: A Phantom Study on Radiation Dose and Image Quality||17/12/2018||201812investigative-radiologyautomatic-tube-current-mod.pdf|
|Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer: Protocol for a European Multicenter Prospective Cohort Study (MEDIRAD EARLY-HEART Study)||08/10/2018||201810_JMIR Research Protocols_Early Detection of Cardiovascular Changes after RT for BC.pdf|
|Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy||07/08/2018||201808_Does deep inspiraton breath-hold prolong life_Radiotherapy and Oncology.pdf|
|MEDIRAD project “implications of medical low-dose radiation exposure”: Enhancing the protection of patients and health professionals from exposure to low-dose medical radiation. S. Grande et al. on behalf of the MEDIRAD Consortium. IL NUOVO CIMENTO 2018||13/11/2019||SGrande et al on behalf of the MEDIRAD Consortium - IL NUOVO CIMENTO 41 C 2018_214.pdf|
|Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer. J. Taprooge et al. Red Journal. 2019||13/11/2019||Compartmental Model for 223Ra-Dichlorides_Flux_RedJournal_2019.pdf|